Research VEGF
Genentech Biooncology

VEGF and prognosis in lung cancer

Several studies have shown that vascular endothelial growth factor (VEGF) is associated with poor prognosis in lung cancer.2,6,14 For information on a particular outcome that has been correlated with VEGF expression, click on the links in the table below.

OutcomeStudy Type and SizeSource
Poor survival Clinical study (N=72)


Meta-analysis of 16 studies
Yuan et al, Int J Cancer (Pred Oncol), 20002

Bremnes et al, Lung Cancer, 20066
Malignant pleural effusionClinical study (N=35)Yeh et al, Oncogene, 200614


Next section

Survival

View references
for this site section